Open Label, Multi-centre, Longitudinal, Prospective, Phase IV Clinical Trial to Compare Two Image Technologies (ImaTx and DXA) Assessing the Anabolic Effects of PTH(1-84) in Postmenopausal Women With Primary Osteoporosis.
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2013
At a glance
- Drugs Parathyroid hormone (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms STEP
- Sponsors Takeda Pharmaceuticals International GmbH
- 04 May 2012 Company (Takeda Global Research and Development Center) added to the associations field as reported by ClinicalTrials.gov record.
- 04 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2011 Planned end date changed from 1 Aug 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.